Silvio Danese

Silvio Danese

UNVERIFIED PROFILE

Are you Silvio Danese?   Register this Author

Register author
Silvio Danese

Silvio Danese

Publications by authors named "Silvio Danese"

Are you Silvio Danese?   Register this Author

100Publications

1613Reads

40Profile Views

Detection and management of early stage inflammatory bowel disease: an update for clinicians.

Expert Rev Gastroenterol Hepatol 2019 Jun 22;13(6):547-555. Epub 2019 Apr 22.

a IBD Center, Department of Gastroenterology , Humanitas Research Hospital , Rozzano, Milan , Italy.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/17474124.2019.1
Publisher Site
http://dx.doi.org/10.1080/17474124.2019.1605291DOI Listing
June 2019

Effectiveness of Infliximab Biosimilar in Crohn's Disease: A Dime, A Dozen.

Gastroenterology 2019 Jun 26;156(8):2349-2351. Epub 2019 Apr 26.

IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center, Rozzano and Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2019.04.029DOI Listing
June 2019

Comorbidities in inflammatory bowel disease: a call for action.

Lancet Gastroenterol Hepatol 2019 Jun 3. Epub 2019 Jun 3.

IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Centre, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(19)30173-6DOI Listing
June 2019

Big data in IBD: a look into the future.

Nat Rev Gastroenterol Hepatol 2019 May;16(5):312-321

INSERM U954 and Department of Hepatogastroenterology, Nancy University Hospital, Université de Lorraine, Vandoeuvre-lès-Nancy, Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41575-019-0102-5DOI Listing
May 2019

Vedolizumab for the treatment of inflammatory bowel diseases: from symptomatic control to mucosal healing.

Immunotherapy 2019 May 12;11(7):565-575. Epub 2019 Mar 12.

Department of Gastroenterology, IBD Center, Humanitas Clinical & Research Center, 20089, Milan, Italy.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/imt-2018-0209
Publisher Site
http://dx.doi.org/10.2217/imt-2018-0209DOI Listing
May 2019

Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).

Dig Liver Dis 2019 May 19;51(5):632-639. Epub 2019 Feb 19.

IBD Unit, Presidio Columbus, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2019.02.004DOI Listing
May 2019

Biosimilar and Originator Product in Inflammatory Bowel Diseases: Mind the Gap?

Curr Med Chem 2019;26(2):246-247

Department of Biomedical Sciences, IBD Center Department of Gastroenterology, Humanitas Research Hospital Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/092986732602190314161008DOI Listing
May 2019

Vedolizumab Treatment in Extra-Intestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review.

J Crohns Colitis 2019 May 10. Epub 2019 May 10.

Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjz095DOI Listing
May 2019

Anti-TNF Biosimilars in Inflammatory Bowel Disease: Searching the Proper Patient's Profile.

Curr Med Chem 2019 ;26(2):280-287

IBD Center, Department of Gastroenterology, Humanitas Research Hospital, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/0929867325666180514100204DOI Listing
April 2019

Loss of Response to Vedolizumab and Ability of Dose Intensification to Restore Response in Patients With Crohn's Disease or Ulcerative Colitis: A Systematic Review and Meta-analysis.

Clin Gastroenterol Hepatol 2019 Apr 20;17(5):838-846.e2. Epub 2018 Jun 20.

Department of Biomedical Sciences, Humanitas University, Milan, Italy; IBD Center, Humanitas Clinical and Research Center, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2018.06.026DOI Listing
April 2019

Treatments for Crohn's Disease-Associated Bowel Damage: A Systematic Review.

Clin Gastroenterol Hepatol 2019 Apr 23;17(5):847-856. Epub 2018 Aug 23.

Translational Gastroenterology Research Unit, GIGA-R, University of Liège, Liège, Belgium; Hepato-Gastroenterology and Digestive Oncology Unit, University Hospital, CHU Liège, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2018.06.043DOI Listing
April 2019

Anti-TNF and postoperative complications in abdominal Crohn's disease surgery.

Curr Drug Targets 2019 Apr 4. Epub 2019 Apr 4.

IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Centre, Rozzano, Milan. Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1389450120666190404144048DOI Listing
April 2019

Noninvasive Multimodal Methods to Differentiate Inflamed vs Fibrotic Strictures in Patients With Crohn's Disease.

Clin Gastroenterol Hepatol 2019 Apr 14. Epub 2019 Apr 14.

Inflammatory Bowel Disease Centre, Humanitas Clinical and Research Centre, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2019.04.025DOI Listing
April 2019

Environmental Risk Factors for Inflammatory Bowel Diseases: an Umbrella Review of Meta-analyses.

Gastroenterology 2019 Apr 20. Epub 2019 Apr 20.

Department of Biomedical Sciences, Humanitas University, Milan, Italy; IBD Center, Humanitas Clinical and Research Center - IRCCS, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2019.04.016DOI Listing
April 2019

Effectiveness of golimumab in ulcerative colitis: A review of the real world evidence.

Dig Liver Dis 2019 03 16;51(3):327-334. Epub 2018 Nov 16.

INSERM U954 and Department of Hepatogastroenterology, Nancy University Hospital, University of Lorraine, Vandoeuvre-lès-Nancy, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15908658183122
Publisher Site
http://dx.doi.org/10.1016/j.dld.2018.11.002DOI Listing
March 2019

Prevention of postoperative recurrence in Crohn's disease: tailoring treatment to patient profile.

Curr Drug Targets 2019 03 19. Epub 2019 Mar 19.

IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Institute, Milan. Italy.

View Article

Download full-text PDF

Source
http://www.eurekaselect.com/170857/article
Publisher Site
http://dx.doi.org/10.2174/1389450120666190320110809DOI Listing
March 2019

Timely Use of Biologics in Early Crohn's Disease: The Return of "Hit Hard and Early"?

Dig Dis Sci 2019 Feb 6. Epub 2019 Feb 6.

INSERM U954 and Department of Gastroenterology, Nancy University Hospital, Université de Lorraine, 1 Allée du Morvan, 54 511, Vandœuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-019-05504-xDOI Listing
February 2019

Biosimilars of adalimumab: the upcoming challenge in IBD.

Expert Opin Biol Ther 2019 Jan 2. Epub 2019 Jan 2.

a IBD Center, Department of Gastroenterology , Humanitas Clinical and Research Institute , Rozzano, Milan , Italy.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14712598.2019.1
Publisher Site
http://dx.doi.org/10.1080/14712598.2019.1564033DOI Listing
January 2019

Vedolizumab Trough Levels and Histological Healing During Maintenance Therapy in Ulcerative Colitis.

J Crohns Colitis 2019 Jan 29. Epub 2019 Jan 29.

INSERM U954 and Department of Hepato-Gastroenterology, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
https://academic.oup.com/ecco-jcc/advance-article/doi/10.109
Publisher Site
http://dx.doi.org/10.1093/ecco-jcc/jjz029DOI Listing
January 2019

Anti-fibrotic Drugs for Crohn's Disease: Ready for Prime Time?

Curr Pharm Des 2019 ;25(1):47-56

IBD Centre, Humanitas Clinical and Research Centre, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612825666190308100844DOI Listing
January 2019

Anti-adhesion Molecules in IBD: Does Gut Selectivity Really Make the Difference?

Curr Pharm Des 2019 ;25(1):19-24

IBD Centre, Humanitas Clinical and Research Centre, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612825666190307165703DOI Listing
January 2019

Biosimilars of Adalimumab in Inflammatory Bowel Disease: Are we Ready for that?

Curr Pharm Des 2019 ;25(1):7-12

IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Institute, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612825666190312113610DOI Listing
January 2019

Interleukin-23 Blockers: Born to be First-line Biologic Agents in Inflammatory Bowel Disease?

Curr Pharm Des 2019 ;25(1):25-31

IBD Centre, Humanitas Clinical and Research Centre, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612825666190313140811DOI Listing
January 2019

Novel Targets for Therapeutic Intervention in Inflammatory Bowel Disease: Research Drives Clinic.

Curr Pharm Des 2019 ;25(1):5-6

IBD Center Department of Gastroenterology Humanitas Clinical and Research Centre Via Manzoni 56, 20089 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138161282501190514105602DOI Listing
January 2019

Unmet Needs in IBD: the Case of Fatigue.

Clin Rev Allergy Immunol 2018 Dec;55(3):368-378

Department of Gastroenterology, Humanitas University, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12016-017-8641-4DOI Listing
December 2018

Role of epithelial-to-mesenchymal transition in inflammatory bowel disease.

J Crohns Colitis 2018 Dec 6. Epub 2018 Dec 6.

IBD Center, Department of Gastroenterology, Humanitas Research Hospital, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
https://academic.oup.com/ecco-jcc/advance-article/doi/10.109
Publisher Site
http://dx.doi.org/10.1093/ecco-jcc/jjy201DOI Listing
December 2018

Meta-Analysis of the Association Between Anti-Tumour Necrosis Factor Use and Lymphoma Risk in Patients With Inflammatory Bowel Disease: Methodological Considerations.

J Crohns Colitis 2018 Nov;12(10):1257-1258

Department of Biomedical Sciences, Humanitas University, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjy094DOI Listing
November 2018

Treatment Persistence of Infliximab Versus Adalimumab in Ulcerative Colitis: A 16-Year Single-Center Experience.

Inflamm Bowel Dis 2018 Oct 16. Epub 2018 Oct 16.

INSERM U954 and Department of Hepatogastroenterology, Nancy University Hospital, Université de Lorraine, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ibd/izy322DOI Listing
October 2018

Positioning Tofacitinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis.

Inflamm Bowel Dis 2018 09;24(10):2106-2112

Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ibd/izy076DOI Listing
September 2018

Colorectal cancer prevention in patients with ulcerative colitis.

Best Pract Res Clin Gastroenterol 2018 Feb - Apr;32-33:103-109. Epub 2018 May 16.

Department of Gastroenterology and NGERE Unit, Inserm, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpg.2018.05.010DOI Listing
September 2018

Should we use anti-tumor necrosis factor agents or vedolizumab as first-line biological therapy in ulcerative colitis?

Best Pract Res Clin Gastroenterol 2018 Feb - Apr;32-33:17-25. Epub 2018 May 12.

Department of Gastroenterology, Nancy University Hospital, Université de Lorraine, 1 Allée du Morvan, 54511, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpg.2018.05.006DOI Listing
September 2018

Safety of biological therapies in ulcerative colitis: An umbrella review of meta-analyses.

Best Pract Res Clin Gastroenterol 2018 Feb - Apr;32-33:43-47. Epub 2018 Jun 11.

Department of Biomedical Sciences, Humanitas University, 20090, Pieve Emanuele, Milan, Italy; IBD Center, Humanitas Clinical and Research Center, 20089, Rozzano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15216918183000
Publisher Site
http://dx.doi.org/10.1016/j.bpg.2018.05.005DOI Listing
September 2018

The impact of biologics in surgical outcomes in ulcerative colitis.

Best Pract Res Clin Gastroenterol 2018 Feb - Apr;32-33:79-87. Epub 2018 Jun 8.

IBD Center, Department of Gastroenterology, Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpg.2018.05.014DOI Listing
September 2018

JAK inhibitors: Novel developments in management of ulcerative colitis.

Best Pract Res Clin Gastroenterol 2018 Feb - Apr;32-33:89-93. Epub 2018 May 23.

Humanitas University, Department of Biomedical Sciences, Rozzano, Milan, Italy; Humanitas Clinical and Research Institute, IBD Center, Rozzano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15216918183005
Publisher Site
http://dx.doi.org/10.1016/j.bpg.2018.05.015DOI Listing
September 2018

Can IL-23 be a good target for ulcerative colitis?

Best Pract Res Clin Gastroenterol 2018 Feb - Apr;32-33:95-102. Epub 2018 May 23.

IBD Centre, Humanitas Clinical and Research Centre, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpg.2018.05.016DOI Listing
September 2018

Review article: treating-to-target for inflammatory bowel disease-associated anaemia.

Aliment Pharmacol Ther 2018 Sep 1;48(6):610-617. Epub 2018 Aug 1.

IBD Center and Department of Biomedical Sciences, Humanitas Clinical and Research Center, Humanitas University, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.14922DOI Listing
September 2018

The nocebo effect: a clinical challenge in the era of biosimilars.

Expert Rev Clin Immunol 2018 09 30;14(9):739-749. Epub 2018 Aug 30.

a Department of Gastroenterology , Nancy University Hospital , Vandœuvre-lès-Nancy , France.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/1744666X.2018.1
Publisher Site
http://dx.doi.org/10.1080/1744666X.2018.1512406DOI Listing
September 2018

Metagenomic analysis of intestinal mucosa revealed a specific eukaryotic gut virome signature in early-diagnosed inflammatory bowel disease.

Gut Microbes 2019 25;10(2):149-158. Epub 2018 Sep 25.

a IBD Center, Laboratory of Gastrointestinal Immunopathology , Humanitas Clinical and Research Center , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/19490976.2018.1511664DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546319PMC
September 2018

Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration.

J Crohns Colitis 2018 Aug;12(suppl_2):S678-S686

IBD Centre, Humanitas Clinical and Research Centre, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjx107DOI Listing
August 2018

Quality of Care in Ulcerative Colitis: A Modified Delphi Panel Approach.

Dig Dis 2018 3;36(5):346-353. Epub 2018 Jul 3.

Center for Observational and Real-World Evidence (CORE), Merck & Co., Inc., Kenilworth, New Jersey, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000489845DOI Listing
August 2018

Evolving strategies and goals of treatment in ulcerative colitis.

Best Pract Res Clin Gastroenterol 2018 Feb - Apr;32-33:1-2

IBD Centre, Humanitas Clinical and Research Centre, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpg.2018.07.001DOI Listing
August 2018

Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease.

Gastroenterology 2018 07 28;155(1):76-87. Epub 2018 Mar 28.

Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2018.03.032DOI Listing
July 2018

Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials.

Expert Opin Investig Drugs 2018 07 6;27(7):595-599. Epub 2018 Jul 6.

a Department of Biomedical Sciences , Humanitas University , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2018.1492547DOI Listing
July 2018

PF-00547659 for the treatment of Crohn's disease and ulcerative colitis.

Expert Opin Investig Drugs 2018 Jul 16;27(7):623-629. Epub 2018 Jul 16.

a IBD Centre, Humanitas Clinical and Research Centre , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2018.1494722DOI Listing
July 2018

Infliximab biosimilar CT-P13 for inflammatory bowel disease.

Lancet Gastroenterol Hepatol 2018 06 30;3(6):373-375. Epub 2018 Mar 30.

Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele 20090, Milan, Italy; IBD Center, Humanitas Clinical and Research Center, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(18)30116-XDOI Listing
June 2018

Diffusion-weighted MRI in inflammatory bowel disease.

Lancet Gastroenterol Hepatol 2018 06;3(6):433-443

Department of Gastroenterology, Nancy University Hospital, Université de Lorraine, Nancy, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(18)30054-2DOI Listing
June 2018

Sexual and reproductive issues and inflammatory bowel disease: a neglected topic in men.

Eur J Gastroenterol Hepatol 2018 Mar;30(3):316-322

IBD Centre, Humanitas Clinical and Research Centre.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MEG.0000000000001074DOI Listing
March 2018

Telehealth in Inflammatory Bowel Disease: Every Patient May Need a Coach!

Gastroenterology 2018 Mar 31;154(4):1196-1198. Epub 2018 Jan 31.

Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2018.01.036DOI Listing
March 2018

Vedolizumab for the treatment of Crohn's disease.

Expert Rev Clin Immunol 2018 03 23;14(3):179-189. Epub 2018 Feb 23.

b IBD Center, Department of Gastroenterology , Humanitas Research Hospital , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1744666X.2018.1438189DOI Listing
March 2018

Novel therapeutic targets for inflammatory bowel disease.

J Autoimmun 2017 Dec 12;85:103-116. Epub 2017 Jul 12.

IBD Center, Department of Gastroenterology, Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaut.2017.07.004DOI Listing
December 2017

Early intervention in Crohn's disease: towards disease modification trials.

Gut 2017 12 5;66(12):2179-2187. Epub 2017 Sep 5.

Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/gutjnl-2017-314519DOI Listing
December 2017

Management of patients with inflammatory bowel disease and spondyloarthritis.

Expert Rev Clin Pharmacol 2017 Dec 20;10(12):1363-1374. Epub 2017 Sep 20.

g Inserm U954 and Department of Gastroenterology , Nancy University Hospital, Université de Lorraine , Vandœuvre-lès-Nancy , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17512433.2017.1377609DOI Listing
December 2017

E-health in inflammatory bowel diseases: More challenges than opportunities?

Dig Liver Dis 2017 Dec 24;49(12):1320-1326. Epub 2017 Aug 24.

Inserm U954 and Department of Gastroenterology, Nancy University Hospital, University of Lorraine, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2017.08.026DOI Listing
December 2017

Comparison of two methods for the in-vivo diagnosis of Helicobacter pylori infection using a tablet of 13C-urea.

Minerva Gastroenterol Dietol 2017 Dec;63(4):319-326

IBD Center, Humanitas Clinical and Research Center, Rozzano, Milan, Italy -

View Article

Download full-text PDF

Source
http://dx.doi.org/10.23736/S1121-421X.17.02411-4DOI Listing
December 2017

Biosimilar Drugs for Inflammatory Bowel Disease: Is Similar Good Enough?

Dig Dis Sci 2017 11;62(11):2964-2965

Division of Gastroenterology, IBD Center, IRCCS Istituto Clinico Humanitas ICH, 20089, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-017-4693-9DOI Listing
November 2017

MFSD2A Promotes Endothelial Generation of Inflammation-Resolving Lipid Mediators and Reduces Colitis in Mice.

Gastroenterology 2017 11 4;153(5):1363-1377.e6. Epub 2017 Aug 4.

IBD Center, Laboratory of Gastrointestinal Immunopathology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2017.07.048DOI Listing
November 2017

Preventing disability in inflammatory bowel disease.

Therap Adv Gastroenterol 2017 Nov 16;10(11):865-876. Epub 2017 Oct 16.

INSERM U954 and Department of Hepatogastroenterology, Nancy University Hospital, Lorraine University, Allée du Morvan, F-54511 Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756283X17732720DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673018PMC
November 2017

Positioning Ustekinumab in Crohn's Disease: From Clinical Evidence to Clinical Practice.

J Crohns Colitis 2017 Oct;11(10):1258-1266

Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjx079DOI Listing
October 2017

Infection Risk With Biologic Therapy in Patients With Inflammatory Bowel Disease.

Clin Pharmacol Ther 2017 Oct 16;102(4):633-641. Epub 2017 Aug 16.

Department of Gastroenterology, IBD Center, Humanitas Clinical and Research Center, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpt.791DOI Listing
October 2017

Adherence to infliximab therapy in inflammatory bowel disease patients in a real-life setting.

J Dig Dis 2017 Oct;18(10):566-573

Inserm U954 and Department of Gastroenterology, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1751-2980.12539DOI Listing
October 2017

IBD: To switch or not to switch: that is the biosimilar question.

Nat Rev Gastroenterol Hepatol 2017 Sep 5;14(9):508-509. Epub 2017 Jul 5.

Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrgastro.2017.86DOI Listing
September 2017

Filgotinib in Crohn's Disease: JAK Is Back.

Gastroenterology 2017 Aug 24;153(2):603-605. Epub 2017 Jun 24.

Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2017.06.040DOI Listing
August 2017

PDE4 Inhibition and Inflammatory Bowel Disease: A Novel Therapeutic Avenue.

Int J Mol Sci 2017 Jun 15;18(6). Epub 2017 Jun 15.

Laboratory of Gastrointestinal Immunopathology, Humanitas Clinical and Research Center, Milan 20089, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms18061276DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486098PMC
June 2017

The Experience with Biosimilars of Infliximab in Inflammatory Bowel Disease.

Curr Pharm Des 2017 ;23(44):6759-6769

IBD Center, Dept. of Gastroenterology, Humanitas Clinical and Research Institute, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612824666171204095342DOI Listing
January 2017